Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector
Related Experiment Video
Updated: Sep 25, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
Published on: June 4, 2012
Marc van de Wetering1, Irma Oving, Vanesa Muncan
1Hubrecht Laboratory, Centre for Biomedical Genetics, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.
Abstract:
We have designed a doxycycline-regulated form of the H1 promoter of RNA polymerase III that allows the inducible knockdown of gene expression by small interfering RNAs (siRNAs). As a proof-of-principle, we have targeted beta-catenin in colorectal cancer (CRC) cells. T-cell factor (TCF) target-gene expression is induced by accumulated beta-catenin, and is the main transforming event in these cells. We have shown previously that the disruption of beta-catenin/TCF4 activity in CRC cells by the overexpression of dominant-negative TCF induces rapid G1 arrest and differentiation. Stable integration of our inducible siRNA vector allowed the rapid production of siRNAs on doxycycline induction, followed by specific downregulation of beta-catenin. In these CRC cells, TCF reporter-gene activity was inhibited, and G1 arrest and differentiation occurred. The inhibition of two other genes using this vector system shows that it should be useful for the inducible knockdown of gene expression.
Insights
Researchers developed an inducible gene knockdown system using doxycycline to control small interfering RNAs (siRNAs). This method effectively reduced beta-catenin in colorectal cancer cells, leading to cell cycle arrest and differentiation.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- Beta-catenin accumulation drives colorectal cancer (CRC) by activating T-cell factor (TCF) target genes.
- Disrupting beta-catenin/TCF4 activity in CRC cells induces G1 arrest and differentiation.
Purpose of the Study:
- To develop a doxycycline-inducible system for gene knockdown using small interfering RNAs (siRNAs).
- To validate the system's efficacy by targeting beta-catenin in colorectal cancer cells.
Main Methods:
- Designed a doxycycline-regulated H1 promoter system for inducible siRNA production.
- Integrated the vector into CRC cells for stable expression.
- Induced siRNA synthesis with doxycycline to target beta-catenin.
Main Results:
- The system enabled rapid siRNA production upon doxycycline induction.
- Specific downregulation of beta-catenin was achieved in CRC cells.
- TCF reporter gene activity was inhibited, resulting in G1 arrest and differentiation.
Conclusions:
- The developed doxycycline-inducible siRNA system provides a powerful tool for gene knockdown.
- This system facilitates the study of gene function in cellular processes like cancer development.
- The vector system's versatility is demonstrated by successful knockdown of other target genes.
Related Concept Videos
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Small interfering RNAs (siRNA)
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
MicroRNAs

